Immunovaccine begins Phase I trial with DPX-RSV vaccine
The Phase 1 study will evaluate the safety and immune response profile of the DPX-RSV vaccine candidate in healthy adults. The study, conducted at the Canadian Center for
The Phase 1 study will evaluate the safety and immune response profile of the DPX-RSV vaccine candidate in healthy adults. The study, conducted at the Canadian Center for
Dr. Daniel Teper, CEO of Immune, commented: "We believe that the new formulation of AmiKet may increase value to potential commercial partners and to Immune. As a result
In addition to this non-contingent license payment of $120.0 million, as previously announced, FibroGen received a $15.0 million milestone payment from AstraZeneca during the second quarter of 2015
This single ascending dose trial will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742 in healthy human volunteers, with results expected in the second half of 2015.
BioBlast is currently conducting a Phase 2 study in patients suffering from SCA3 in Israel. Cabaletta is a chemical chaperone that has been shown to prevent pathological aggregation
The acquisition further enhances BSN medical’s comprehensive product portfolio for the management of lymphatic and venous disorders under the JOBST and Elvarex brands. "This acquisition benefits BSN and
Pursuant to the amendment, Sandoz will increase its commercial investment in KERYDIN in 2015, and Anacor will contribute $20 million to Sandoz, primarily focused on consumer-directed commercialization activities.
In the last three years, Pro Bono Bio has successfully launched and grown Flexiseq and Flexiseq Sport across the UK and other global markets including Europe, Asia and
With access to these funds, WCCT Global is pursuing both strategic organic expansion and new research capabilities within Asia and Europe, with the intent of improving their early
BARDA is a division of the U.S. Department of Health and Human Services that manages the advanced development and purchase of medical countermeasures for public health threats. Aeolus